Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachmann, S.
Right arrow Articles by Willnow, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachmann, S.
Right arrow Articles by Willnow, T. E.
J Am Soc Nephrol 15:892-900, 2004
© 2004 American Society of Nephrology


BASIC SCIENCE

Kidney-Specific Inactivation of the Megalin Gene Impairs Trafficking of Renal Inorganic Sodium Phosphate Cotransporter (NaPi-IIa)

Sebastian Bachmann*, Uwe Schlichting*, Beate Geist*, Kerim Mutig*, Thomas Petsch*, Desa Bacic{ddagger},§, Carsten A. Wagner{ddagger}, Brigitte Kaissling§, Jürg Biber{ddagger}, Heini Murer{ddagger} and Thomas E. Willnow{dagger}

*Department of Anatomy, Charité, University Medical School of Berlin, and {dagger}Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany; and Departments of {ddagger}Physiology and §Anatomy, University of Zürich, Switzerland.

Correspondence to: Prof. Dr. Sebastian Bachmann, AG Anatomie der Charité, Campus Mitte, Philippstr. 12, D-10098 Berlin, Germany. Phone: +49-30-450-528-001; Fax: +49-30-450-528-922; E-mail: sbachm{at}charite.de


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ABSTRACT. Renal reabsorption of inorganic phosphate is mediated by the type IIa sodium phosphate cotransporter (NaPi-IIa) of the proximal tubule. Changes in renal phosphate handling are mainly attributable to altered NaPi-IIa brush border membrane (BBM) expression. Parathyroid hormone (PTH) induces inactivation of NaPi-IIa by endocytic membrane retrieval and degradation. The key elements triggering this process are not clear to date. Megalin serves as a receptor for the endocytosis of multiple ligands and is coexpressed with NaPi-IIa in the proximal tubule. Investigated was the role of megalin in the regulation of NaPi-IIa in steady state and during inactivation. Kidneys and tubular BBM fractions from mice with a renal-specific megalin gene defect and from controls were analyzed by light and electron microscopic histochemical techniques and Western blot test. Steady-state levels of NaPi-IIa in BBM were significantly enhanced, mRNA levels preserved, and phosphaturia reduced in the absence of megalin. Fluid-phase endocytosis was prevented and the apical endocytic apparatus markedly reduced. Systemic administration of PTH resulted in a defective retrieval and impaired degradation of NaPi-IIa. In vitro, the application of various stimuli of the PTH-induced signaling cascade had no effect either. Adequate steady-state expression of NaPi-IIa and the capacity of the proximal tubule cell to react on PTH-driven inactivation of NaPi-IIa by endocytosis and intracellular translocation require the presence of megalin.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Homeostasis of inorganic phosphate (Pi) is maintained by the balancing of intestinal reabsorption and renal excretion of Pi. The action of the NaPi-IIa cotransporter of the proximal tubule brush border membrane (BBM) accounts for more than 70% of the renal uptake of Pi (1,2). Rapid up- or downregulation of the transporter subsequent to acute changes in phosphate intake or parathyroid hormone (PTH) levels is based on posttranscriptional events including intracellular trafficking, rather than on transcriptionally regulated changes in the mRNA levels of NaPi-IIa (3). Histochemical analysis has demonstrated that the transporter is either inserted into the BBM upon an increased need for Pi reabsorption or selectively retrieved from the BBM in the course of its downregulation. Retrieval occurs via endocytosis driving the internalization of the transporters. Cell biologic landmarks of the retrieval process have been identified in much detail (4–6). Accordingly, cellular structures involved are the clathrin-coated pits, endocytic vesicles, lysosomes, and the dense apical tubules (DAT) involved in membrane recycling. In a first step of its rapid downregulation by PTH or high Pi intake, NaPi-IIa thus accumulates transiently in the apical endocytic compartment of the proximal tubule before being degraded in a second step in the lysosomes within one to several hours thereafter (4,6). Retrieval coincides with quantitative changes in the vesicular compartment including the DAT (6–8). Similarities of this process with receptor-mediated endocytosis of ligands have been highlighted (6,9,10).

At the molecular level, the regulation of NaPi-IIa is presently under active investigation. Open questions refer to the mechanisms of transmitting signals for retrieval and intracellular trafficking of the transporter (11). Insights came from patient data on Fanconi type syndromes and from knockout mouse models with gene defects interfering with endocytosis, calciotropic hormones, and the handling of various ligands to proximal tubule receptors (9,10). A knockout of the clcn5 gene encoding the vesicular chloride channel ClC-5 produced characteristics of Dent disease, which are based on a defective acidification of endosomes and an impaired vesicle trafficking (9,12). In this model, hyperphosphaturia was described along with a concentration of NaPi-IIa in the apical endocytic compartment. It was assumed that these impairments were related to elevated urinary and hence luminal PTH concentrations. In line with this hypothesis, the amount of megalin, an endocytic multiligand receptor that also degrades PTH from the proximal tubule filtrate (10,13), was downregulated in this model (9,14). It was argued, therefore, that higher PTH availability was related to the downregulation of NaPi-IIa in steady state (9). Experimentally induced retrieval of NaPi-IIa was observed in these mice nevertheless, although at reduced efficiency. The role of receptor-associated protein (RAP), which has been identified as a chaperone-like protein interfering with megalin and related receptors, has further been discussed in this context. The RAP knockout mouse showed a retardation in PTH-induced effect that may be related to an altered distribution of megalin (15,16). An interaction of megalin with a membrane protein of the proximal tubule has further been reported (17).

The rationale of the study presented here was to investigate the role of megalin in PTH-dependent inactivation of NaPi-IIa by the use of mice with a kidney-specific megalin defect induced by conditional gene targeting. These mice have been characterized in a previous study of our group (18). The renal inactivation of megalin permits the parallel study of NaPi-IIa in megalin-expressing and megalin-deficient proximal tubule cells in response to the hormonal stimulus. We have addressed the question whether the absence of the receptor interferes with the kidney’s ability to regulate its major NaPi cotransporter. Related changes in the endocytic capacity of the proximal tubule were analyzed in detail.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals and Treatments
Experiments were performed in adult male conditional megalin knockout mice (megalin lox/lox; apoECre), here termed Cre(+), and in controls (megalin lox/lox), termed Cre(-) (18); body weight 15 to 25 g, age 10 to 15 wk. Remnant megalin expression in Cre(+) was standardized by testing urinary levels of D binding protein (18) because the extent of megalin gene deletion in Cre(+) ranged from 50% to 90% of tubules lacking megalin. In brief, overnight urine samples were collected and subjected to SDS-PAGE and Western blot analysis with anti-DBP antiserum (DACO). The intensity of the DBP signal in individual samples was compared with the signal generated by defined amounts of purified mouse DBP run in parallel. Animals producing approximately 50 µg DBP/ml urine, reflecting 70% to 90% gene deletion, were used in the study. Mice were allowed free access to standard chow containing 0.8% Pi. Drinking water was supplemented with 4% calcium gluconate and 3% calcium lactate 24 h before drug or vehicle treatment to keep endogenous PTH levels low and to standardize NaPi-IIa expression (6).

To study the effect of PTH, mice were divided into two groups of Cre(+) or Cre(-) mice (n = 20 each), each receiving either an intraperitoneal injection of vehicle (0.9% NaCl) or PTH (1-34) fragment (Sigma; 1 µg per 10g body mass) 30 min before sacrifice, as described (6). Each group was further divided into two subgroups, each composed of n = 10, which after treatment either served for biochemical analysis, or for perfusion-fixation and histochemical analysis. Before sacrifice mice were anesthetized with sodium pentobarbital. To study fluid-phase endocytosis, horseradish peroxidase (HRP; Sigma; 120 µg/g body weight) was given to mice (each n = 3) under anesthesia via laparotomy and intravenous injection between 10 and 30 min before perfusion-fixation.

Kidney Slices
For slice preparation, kidneys from untreated Cre(+) and Cre(-) mice were prepared and slices incubated as described (16). One-millimeter-thick kidney slices were left untreated for control, or treated with PTH (1-34) fragment, 8-Br-cAMP, 8-Br-cGMP, or 1,2-dioctanoyl-sn-glycerol (DOG). During the course of the experiment, all solutions were gassed with 5% CO2/ 95% O2, and the pH was kept constant at pH 7.4 ± 0.2. Experiments were performed at least in double each with two kidneys used from two different mice. Untreated and PTH-treated slices were used in all experiments as internal controls.

Semiquantitative RT-PCR
Kidneys were rapidly dissected, homogenized, and lysed, and total RNA was prepared with the RNeasy-total-RNA kit (Quiagen). After digestion of genomic DNA by treatment with DNase, cDNA was synthesized by reverse transcription of 5 µg total RNA, with a cDNA synthesis kit (Invitrogen). cDNA fragments between bases 1276 to 1576 (GenBank accession no. L33878) for NaPi-IIa and from base 742 to 1047 (no. M17701) for GAPDH were amplified. The following sets of oligonucleotide primers were used: NaPi-IIa 5'-gTC CAg AgC AgC TCC gTg TT-3' and 5'-CAg CAA ACC AgC ggT ACT Tg-3' (300 bp); GAPDH: 5'-TAT CCg TTg Tgg ATC TgA C-3' and 5'-Tgg TCC Agg ggT TTC TTA C-3' (304 bp). Amplification was done with Taq polymerase (Life Technologies) over 23 to 35 cycles with an automated thermal cycler (Perkin-Elmer). Each cycle comprised denaturation at 94°C, annealing at 60°C, and extension at 72°C for 1 min each. The number of cycles was adapted for both products to obtain linear correlation between signal intensities of RT-PCR product and cDNA concentration. PCR products were analyzed by agarose gel electrophoresis and stained with ethidium bromide.

BBM Preparation
After removal, kidneys were shock-frozen and processed as described (6,19). In brief, kidneys were homogenized and BBM fractions prepared (19). Purity of the preparation was checked by comparing the activity of the BBM marker enzymes, {gamma}-glutamyltransferase [{gamma}-GT; (20)] and alkaline phosphatase [AP; (21)] in BBM fractions versus total homogenate. {gamma}-GT and AP kits ({gamma}-glutamyl transpeptidase [GGT] and ALP IFCC liquid; Roche) were used for determination. Total protein concentration was measured with a BCA kit (Pierce).

Western Blot Tests
Samples of the total homogenates and BBM fractions were electrophoresed under reducing conditions on 10% SDS polyacrylamide gels. Each lane was loaded with 40 µg of protein, and the proteins were electrotransferred onto nitrocellulose membranes. Equal loading was controlled by use of Ponceau red stain. Membranes were blocked and incubated with primary polyclonal rabbit anti-rat NaPi-IIa antibody [dilutions 1:500 to 1:4,000; (2)] and secondary horseradish peroxidase-conjugated goat anti-rabbit IgG (Dako; 1:2,000 dilution), followed by chemiluminescence reagent (ECL, Amersham). The resulting signals were densitometrically analyzed with a scanner and Bio-Profil Bio1D software. Results were summed intensity values; controls were set to 100% as a mean internal standard, and experimental levels were compared with standard.

Histochemistry of Perfusion-Fixed Mice
Kidneys were perfusion-fixed by retrograde cannulation of the abdominal aorta with 3% paraformaldehyde as described (22). Immunolabeling was performed on cryostat or paraffin sections of 5 µm thickness, blocked with 5% milk powder in PBS, incubated for 2 h with primary antibodies (sheep anti-megalin [1:2,500 dilution (15)] and rabbit anti–NaPi-IIa [1:400 dilution]), followed by secondary antibodies (Cy3-coupled donkey-anti sheep IgG and Cy2-coupled swine-anti rabbit IgG [Dianova]). Specificity of the double-staining procedures was controlled by parallel incubation of consecutive sections, each incubated only with one single probe. For HRP histochemistry, cryostat sections were incubated with diaminobenzidine added with H2O2. Controlling for general BBM antibody staining intensity we have tested antibodies against sodium sulfate cotransporter (NaSi-1) and sodium hydrogen exchanger-3 (NHE-3) as described (16).

Histochemistry of Slices
After incubation, slices were transferred to fixative (16), mounted onto cork plates, and frozen. Cryostat sections were then incubated with NaPi-IIa antibody (dilution 1:1500) followed by swine anti-rabbit IgG conjugated to FITC (Dako). For double staining of NaPi-IIa and {beta}-actin filaments, rhodamine-phalloidin was used (Molecular Probes; dilution 1:50). Reagents were added as previously described (16).

Ultrastructural Analysis
Conventional electron microscopy (EM) was performed on perfusion-fixed tissue embedded in Epon 812 (Serva). For immuno-EM, small tissue samples were cryo-substituted in a freeze-substitution unit (Leica) and infiltrated with London LR-White hydrophilic resin (Science Services). Ultrathin sections were incubated with anti–NaPi-IIa (1:300 dilution) or anti-megalin antibody (1:5,000 dilution) followed by 5 nm gold-labeled goat anti-rabbit IgG (Amersham) or 12 nm gold-labeled donkey anti-sheep IgG (Dianova), respectively, and subsequently silver impregnated (AuroProbe, Amersham). For morphometry, EM pictures of the luminal cell pole and BBM were taken at random from PTH or vehicle treated Cre(+) mice (n = 3 each) to evaluate immunogold staining intensity in the respective compartment. A total of 96 micrographs, each containing a single cell from proximal S1/S2 segments with versus without remnant megalin expression as identified by the presence or absence of DAT, was evaluated.

In Situ Hybridization
Digoxigenin (DIG)-11-UTP–labeled riboprobes were synthesized by in vitro transcription (DIG RNA labeling kit [Sp6/T7]; Roche) with a full-length mouse NaPi-IIa cDNA in the pSport 1 vector (Invitrogen). After linearization with NotI or SalI, sense or antisense riboprobes were generated with T7 and SP6 RNA polymerases, respectively, as described (22). Seven-micron-thick paraffin sections from perfusion-fixed tissue were treated according to established methods (23). Signal was generated with 4-nitroblue tetrazolium chloride. For control, sense probes were applied in parallel with antisense probes. For double staining with anti-megalin antibody and fluorescence-labeled secondary antibody, incubations were started thereafter and performed as detailed above.

Statistical Analyses
Biochemical and morphometric values are means ± SEM. Statistical significance of differences was evaluated by the Wilcoxon signed rank test, Mann-Whitney Wilcoxon test, and unpaired t test, as appropriate.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We first analyzed the steady state distribution of NaPi-IIa in Cre(-) versus Cre(+) mice. In controls, antibody to NaPi-IIa strongly labeled the proximal convolutions (S1 and S2 segments) with staining located mainly in the BBM and, to a minor extent, also in intracellular structures (Figures 1 to 3GoGo). Signal was high in the inner cortical labyrinth, weaker in midcortical and superficial convolutions, and absent from the straight segments. Similar results were obtained by in situ hybridization for NaPi-IIa mRNA. In contrast, concomitant immunostaining for megalin invariably labeled all parts of the proximal tubule with no evidence for regional heterogeneity (Figure 1, a and a'). The kidney-specific inactivation of megalin in Cre(+) mice was incomplete, probably owing to a variable efficiency of the Cre recombinase (18), which resulted in a remnant expression of megalin in approximately 10% to 25% of the nephrons (Figure 1, b and b'). Individual nephrons were showing half megalin-positive, and half negative profiles of the proximal tubule (Figure 4, b and b', and Figure 5a). NaPi-IIa staining in Cre(+) was concentrated in the same areas of the cortex as in Cre(-); however, staining was also detectable in mid- and outer cortical proximal convolutions, and BBM signal was particularly strong throughout, whereas intracellular labeling was weaker than in controls. This was also reflected by the quantitative evaluation of Western blots showing a 69.5% higher abundance of NaPi-IIa in BBM of Cre(+) compared with Cre(-) in steady state, and extracts from total kidney homogenate showed increases as well (Figure 6). Significantly decreased urinary phosphate excretion (-53.5%) in Cre(+) further supported the enhanced availability of the cotransporter at its site of action (Figure 7b). By contrast, strength and distribution of NaPi-IIa mRNA expression were apparently independent of the presence of megalin, because these were similar in both strains as studied by in situ hybridization and semi-quantitative RT-PCR evaluation, and sites with remnant megalin expression showed the same NaPi-IIa mRNA signal as megalin-deficient tubules in comparable position (Figure 2, a and a', and Figure 7a). The immunoreactive signal intensity of other transporters of BBM such as NaSi-1 and NHE-3 was unaltered as well (Figure 8).



View larger version (158K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Immunofluorescence, with double staining on the same section for megalin (left; a and b) and type IIa sodium phosphate cotransporter (NaPi-IIa) (right; a' and b'). Stippled lines mark the border between inner cortical labyrinth and outer stripe. Scattered proximal tubule profiles exhibit remnant expression in Cre(+) tissue.

 


View larger version (97K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Combined in situ hybridization for type IIa sodium phosphate cotransporter (NaPi-IIa) mRNA (a) and immunohistochemistry for megalin (a'). mRNA signal is not affected by remnant megalin expression.

 


View larger version (98K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Comparative aspects between proximal tubules from controls and megalin-deficient mice. (a through d') Effect of intraperitoneal administration of parathyroid hormone (PTH) [PTH(+)] or vehicle [PTH(-)] for 30 min. Each pair of figures shows megalin (red) and type IIa sodium phosphate cotransporter (NaPi-IIa) (green) immunofluorescence on double-stained sections. (a through b') PTH administration causes retrieval of NaPi-IIa signal from the BBM compared with vehicle, as evidenced by weaker BBM and diffuse cytoplasmic staining in controls. (c through d') Portions entirely or locally (between bars) lacking megalin show absence of retrieval of NaPi-IIa upon PTH administration.

 


View larger version (129K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Dysfunction of the endocytic apparatus of the proximal convoluted tubule. (a and a') Electron microscopy (EM) showing the absence of dense apical tubules (DAT) and reduction of the endocytic apparatus in megalin deficiency. (b and b') Coordinate signals for megalin (red fluorescence signal in brush border membrane [BBM]) and horseradish peroxidase (HRP) (black signal in endocytic compartment 17 min after HRP injection) demonstrate that endocytosis depends on megalin. (c and c') EM showing endocytosed HRP in DAT and endosomal apparatus in controls but not in megalin deficiency.

 


View larger version (65K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 5. Parallel immunogold staining of megalin and type IIa sodium phosphate cotransporter (NaPi-IIa) in proximal tubule from Cre(+) mice. (a) To the left, portion of a cell with remnant expression of megalin concomitantly shows electron-dense apical dense apical tubules (DAT) (arrows), whereas megalin-deficient adjacent cell profiles (right) are lacking DAT. (b and c) After parathyroid hormone (PTH) administration, cells lacking megalin, as evidenced by the absence of DAT, concentrate their NaPi-IIa immunostaining in brush border membrane (BBM) but show no retrieval (b), whereas cells with remnant megalin expression, evident by DAT (c; arrows), show an increased intracellular signal due to intact retrieval.

 


View larger version (24K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 6. Immunoreactive type IIa sodium phosphate cotransporter (NaPi-IIa) abundance (densitometry from Western blot test). (a through c) Abundances of NaPi-IIa immunoreactivity in brush border membrane (BBM) fractions and total kidney homogenates from untreated and parathyroid hormone (PTH)–treated Cre(-) (white bars) versus Cre(+) mice (black bars). (d) Representative blots from BBM fractions of n = 3 mice from each group.

 


View larger version (16K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 7. (a) Type IIa sodium phosphate cotransporter (NaPi-IIa) mRNA expression by semiquantitative RT-PCR from total kidney homogenates. Representative results of 4 mice from each group. (b) Urinary phosphate excretion normalized for urinary creatinine.

 


View larger version (184K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 8. Immunofluorescent staining of NHE3 (a and a') and NaSi-1 (b and b'). These antigens show similar intensity of fluorescence signal in brush border membrane (BBM) of both genotypes.

 
The lack of megalin results in a reduction of the subapical cell compartment (18). In particular, the anastomosing network of DAT, an organelle that has a characteristic spinelike protein coat covering its inner surface and mostly lacks an external clathrin coat (8), was absent (Figure 4, a and a'). HRP, a marker of fluid phase endocytosis, was intravenously applied to study alterations of this process with respect to megalin deficiency. A complete absence of HRP uptake was observed in Cre(+), whereas significant subapical endo- and lysosomal staining throughout all proximal tubules was evident in Cre(-) and in tubules of Cre(+) mice with remnant megalin expression (Figure 4, b and b'). As viewed by EM, extensive HRP staining of the endocytic vesicles, endosomes and DAT profiles was seen in intact cells, but not in cells lacking megalin (Figure 4, c and c', and Figure 5a).

To test the effect of an impaired endocytosis on the trafficking and inactivation of NaPi-IIa in proximal tubule, PTH was administered intraperitoneally for 30 min and kidneys were evaluated by immunohistochemistry and Western blot test. In controls the expected internalization of NaPi-IIa immunoreactive signal into the subapical compartment of the proximal tubule with concomitant reduction in BBM signal intensity was observed in agreement with previous results (24) (Figure 3, a and b'). This effect was undetectable in tubules lacking megalin expression (Figure 3, c and d'). Profiles with partial remnant expression confirmed this result revealing that megalin signal and NaPi-IIa retrieval were interrupted coordinately (Figure 3, d and d'). Ultrastructural analysis that used immunogold staining extended this finding showing that an increase in intracellular NaPi-IIa signal, indicative of a retrieval of the cotransporter into the subapical compartment, was only found in cells with intact DAT (Figure 5, b and c). Morphometry confirmed these observations (Table 1). Our results thus suggest a cell-autonomous defect of PTH-induced NaPi-IIa internalization that depends on the presence of megalin, rather than on systemically mediated changes.


View this table:
[in this window]
[in a new window]

 
Table 1. Ratio of BBM versus apical cytoplasmic immunogold staining for NaPi-IIaa
 
Western blot test of BBM preparations revealed that 30 min after PTH injection NaPi-IIa abundance was reduced to 45% in Cre(-) mice, whereas in Cre(+) reduction was only to 77% (Figure 6, b and c). In parallel, a significant reduction was also seen in blots from total homogenate of Cre(-), but not Cre(+) kidneys suggesting that selectively in controls, some of the cotransporter was degraded intracellularly. To verify that the observed changes in BBM content of NaPi-IIa among groups were specific and not biased by structural alteration, the activities of two unrelated BBM-bound marker enzymes, i.e. GGT and AP, were measured. No significant differences in activity were detected between strains for GGT and AP in Cre(+) versus Cre(-), respectively. compared with crude homogenate, GGT activity revealed a 4.8-fold increase and AP a 4.9-fold increase in the BBM fraction, indicating a significant enrichment in the respective enzyme activity and a successful isolation of the BBM fraction. Disruption of megalin in Cre(+) mice therefore did not generally alter the BBM composition.

To examine if changes in the coupling of PTH receptors to previously identified intracellular signaling cascades could be responsible for the observed differences in PTH-induced NaPi-IIa internalization (11), we stimulated these cascades directly. Incubation of kidney slices from Cre(-) mice with the protein kinase C pathway activator DOG (1 µM), 8-Br-cAMP (1 mM), or 8-Br-cGMP (1 mM) led to internalization of NaPi-IIa from the brush border after 45 min as demonstrated earlier (16). However, no internalization occurred after 45 min in kidney slices from Cre(+) mice suggesting that the defect lies not in coupling of PTH receptors to signaling pathways but in a common mechanism for all endocytic signals (Figure 9, a through e').



View larger version (64K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 9. Effects of incubation of kidney slices with vehicle (a, a'), 100 nM parathyroid hormone (PTH) (b, b'), 1 mM 8-Br-cAMP (c, c'), 1 mM 1,2-dioctanoyl-sn-glycerol (DOG) (d, d'), or 1 mM 8-Br-cGMP (e, e') for 45 min. Although these conditions induce retrieval of type IIa sodium phosphate cotransporter (NaPi-IIa) from the brush border membrane in controls, no changes are evident in Cre(+). NaPi-IIa, green; actin, red.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The study presented here aimed to investigate whether action and regulation of the major renal sodium-phosphate cotransporter NaPi-IIa of the proximal tubule depend on the expression of the multiligand receptor megalin. Our results show that in mice with kidney-specific disruption of the megalin gene, distribution and regulation of NaPi-IIa of the proximal tubule are substantially affected. Megalin forms an interactive dual-receptor complex with its tandem receptor, cubilin, and this complex acts as a scavenger to transport proteins into epithelial cells via endocytosis (10). In the renal tubule megalin has been shown to clear low-molecular-weight proteins, which have passed through the glomerular filter, from the proximal tubular fluid. Megalin has further been recognized to determine also more complex functions, which include the tissue-specific steroid uptake, the maintenance of the cell’s vesicular trafficking apparatus, and a possible role in intracellular signaling (10,18,25).

A typical membrane protein like NaPi-IIa may not per se be viewed as a conventional ligand for megalin, and in fact, immunoprecipitation studies failed to show interaction between the two molecules (17). On the other hand, NaPi-IIa requires a broad spectrum of protein interaction for adequate trafficking (3), and its inactivation has been shown to depend on endocytosis, which suggests a role for megalin (24).

Analyzing the defects in NaPi-IIa regulation caused by the genetic manipulation in Cre(+) mice, cell-autonomous effects are to be distinguished from global systemic effects induced by the genetic manipulation. At steady state, a number of renal changes have resulted from the inactivation of the megalin gene. There was moderate, but significant remnant expression of megalin, which permitted the parallel study of megalin-deficient versus intact nephrons within one sample, and may functionally stand for some compensatory capacity protecting against physiologic imbalance unless additional effects were superimposed, as shown previously for the vitamin D metabolism (18). Accordingly, serum calcium, Pi and PTH levels were not significantly altered at steady state. Still, the absence of megalin resulted in a severe global reabsorption deficiency and low molecular weight proteinuria as in the full knockout mouse, and reduced phosphaturia (25,26). Together, the systemic parameters in Cre(+) nonetheless do not suggest direct influences on the observed defects in NaPi-IIa regulation.

Among the principal factors indicating cell-autonomous impairment of NaPi-IIa regulation in Cre(+), the obvious structural alteration of the proximal tubule cell and the resulting effect on the reabsorption of proteins must be considered. In fact, the number of luminal invaginations and endocytic vesicles were substantially reduced in Cre(+) mice, and as a particular structure, the DAT representing a variable membrane pool between endosomes and recycling vesicles (8) were completely absent from proximal tubule cells lacking megalin. HRP, the marker for fluid phase endocytosis that codistributes with NaPi-IIa during PTH-induced inactivation of the transporter (24), was strikingly absent from megalin-deficient cells. This implies that not only the ligand-specific uptake of proteins (10), but also the general, nonspecific reabsorption from the filtrate was disrupted. The reduction of the vacuolar apparatus may be causally related with reduced protein reabsorption, as previously suggested (7), and a consequent impairment of NaPi-IIa trafficking appears plausible. The comparable phenotype of the chloride channel (ClC-5)-deficient mouse resembles the Cre(+) model with respect to proteinuria, downregulation of megalin, impairment of receptor-mediated and fluid-phase endocytosis, and shows reduced internalization of NaPi-IIa (9); however, these changes are not associated with obvious structural alterations, and they are more gradual than in Cre(+), even though they seem to indirectly depend on megalin availability as well (14).

The enhanced concentration of immunoreactive NaPi-IIa in BBM and more widespread distribution of the signal in Cre(+) during steady state condition, typically associated with preserved mRNA levels (3), may thus result from an impairment of endocytic removal that would otherwise be active to regulate the constitutive turnover of the transporter. Surprisingly, the localization of NaPi-IIa in the ClC-5 knockout showed a conspicuous redistribution from the BBM toward the endosomal compartment in steady state. It has been argued that a defect in megalin-dependent inactivation of luminally bound PTH leading to inadequate stimulation of PTH receptors could have caused this effect; this interpretation was underlined by the moderate increase in urinary PTH and phosphaturia (9,13). Because excreted PTH levels in Cre(+) were much higher than in ClC-5 knockouts, whereas BBM NaPi-IIa expression and phosphaturia were changed in opposite direction, the profound alterations of the endocytic apparatus in Cre(+) would explain this discrepancy. In addition, the substantial intracellular alterations of the proximal tubule in Cre(+) mice may also have an effect on mechanisms controlling NaPi-IIa stability, because lysosomes were less frequent than in controls.

In agreement with these considerations, the failure to internalize NaPi-IIa in Cre(+) mice in response to PTH shown in the present in vitro and in vivo material is clearly dependent on megalin deficiency, as visualized at the cell level and underlined by ultrastructural and biochemical techniques. Comparison with the ClC-5 knockout mouse further specifies the need for intact megalin-dependent endocytosis to inactivate NaPi-IIa upon the application of PTH; in fact retrieval of NaPi-IIa from a stimulated baseline condition was similarly impaired as in the present model (9). The application of pharmacologic agents mimicking the effects of a signaling cascade triggered by the PTH receptor to inactivate NaPi-IIa failed to induce changes as well, so that obviously these pathways, which involve adenylate cyclase- and phospholipase C–generated cAMP, IP3, DAG, and a rise in cellular Ca2+ (11) were inefficient in the absence of megalin. Similar observations were made in the RAP knockout mouse with reduced megalin availability (16).

Considering a specific, direct relation between NaPi-IIa and megalin beyond general endocytosis mechanisms that could be relevant for internalization of the transporter, one may assume at least some protein-protein interaction should exist between the two gene products. However, no interaction has been demonstrated by several biochemical techniques up to date. Yet the manyfold and complexity of cytoplasmic adapter proteins, some of which have been defined for each, megalin and NaPi-IIa [for review, (10,27)], provide so far unrecognized means of an interaction that may support a more direct relation between megalin and NaPi-IIa during inactivation of the cotransporter. A relation between megalin deficiency and the expressional pattern of other local transporters such as NaSi-1 and NHE-3 was not evident from steady state analysis, as presented here. The question as to the acute regulation of NHE-3 by PTH and a possible involvement of megalin was not tested, because in the past we had not been able to observe an acute internalization of NHE-3 from the BBM in various comparable mouse models (unpublished observations).

We therefore suggest that proximal tubular NaPi-IIa handling is severely affected in a mouse model with kidney-specific inactivation of the megalin gene. Megalin deficiency induces an ultrastructural anomaly of the endocytic apparatus and interferes with fluid-phase endocytosis, resulting in an enhanced BBM insertion of NaPi-IIa, reduced phosphaturia, and an impaired PTH-induced retrieval of the cotransporter. The profound disruption of endocytosis appears to be the predominant cause for NaPi-IIa dysfunction, although further, as yet unknown interactions of the cotransporter and megalin may matter as well.


    Acknowledgments
 
This study was supported by the Deutsche Forschungsgemeinschaft (Ba 700/10-2; S.B.) and by the Bundesministerium für Bildung und Forschung (NGF network; S.B.). We thank Kerstin Riskowsky for expert technical help and Andreas Lun for determining the clinical parameters.


    Footnotes
 
Dr. Bachmann and Uwe Schlichting contributed equally to this study.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS: Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A 95: 5372–5377, 1998[Abstract/Free Full Text]
  2. Custer M, Lotscher M, Biber J, Murer H, Kaissling B: Expression of Na-P(i) cotransport in rat kidney: Localization by RT-PCR and immunohistochemistry. Am J Physiol 266: F767–F774, 1994
  3. Murer H: Functional domains in the renal type IIa Na/P(i)-cotransporter. Kidney Int 62: 375–382, 2002[CrossRef][Medline]
  4. Pfister MF, Ruf I, Stange G, Ziegler U, Lederer E, Biber J, Murer H: Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proc Natl Acad Sci U S A 95: 1909–1914, 1998[Abstract/Free Full Text]
  5. Keusch I, Traebert M, Lotscher M, Kaissling B, Murer H, Biber J: Parathyroid hormone and dietary phosphate provoke a lysosomal routing of the proximal tubular Na/Pi-cotransporter type II. Kidney Int 54: 1224–1232, 1998[CrossRef][Medline]
  6. Lotscher M, Scarpetta Y, Levi M, Halaihel N, Wang H, Zajicek HK, Biber J, Murer H, Kaissling B: Rapid downregulation of rat renal Na/P(i) cotransporter in response to parathyroid hormone involves microtubule rearrangement. J Clin Invest 104: 483–494, 1999[Medline]
  7. Cui S, Mata L, Maunsbach AB, Christensen EI: Ultrastructure of the vacuolar apparatus in the renal proximal tubule microinfused in vivo with the cytological stain light green. Exp Nephrol 6: 359–367, 1998[CrossRef][Medline]
  8. Hatae T, Fujita M, Sagara H, Okuyama K: Formation of apical tubules from large endocytic vacuoles in kidney proximal tubule cells during absorption of horseradish peroxidase. Cell Tissue Res 246: 271–278, 1986[CrossRef][Medline]
  9. Piwon N, Gunther W, Schwake M, Bosl MR, Jentsch TJ: ClC-5 Cl- channel disruption impairs endocytosis in a mouse model for Dent’s disease. Nature 408: 369–373, 2000[CrossRef][Medline]
  10. Christensen EI, Birn H: Megalin and cubilin: Multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3: 256–266, 2002[Medline]
  11. Murer H, Hernando N, Forster I, Biber J: Proximal tubular phosphate reabsorption: Molecular mechanisms. Physiol Rev 80: 1373–1409, 2000[Abstract/Free Full Text]
  12. Gunther W, Piwon N, Jentsch TJ: The ClC-5 chloride channel knock-out mouse—An animal model for Dent’s disease. Pflügers Arch 445: 456–462, 2003[Medline]
  13. Hilpert J, Nykjaer A, Jacobsen C, Wallukat G, Nielsen R, Moestrup SK, Haller H, Luft FC, Christensen EI, Willnow TE: Megalin antagonizes activation of the parathyroid hormone receptor. J Biol Chem 274: 5620–5625, 1999[Abstract/Free Full Text]
  14. Christensen EI, Devuyst O, Dom G, Nielsen R, Van der SP, Verroust P, Leruth M, Guggino WB, Courtoy PJ: Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci U S A 100: 8472–8477, 2003[Abstract/Free Full Text]
  15. Birn H, Vorum H, Verroust PJ, Moestrup SK, Christensen EI: Receptor-associated protein is important for normal processing of megalin in kidney proximal tubules. J Am Soc Nephrol 11: 191–202, 2000[Abstract/Free Full Text]
  16. Bacic D, Capuano P, Gisler SM, Pribanic S, Christensen EI, Biber J, Loffing J, Kaissling B, Wagner CA, Murer H: Impaired PTH-induced endocytotic down-regulation of the renal type IIa Na(+)/P(i)-cotransporter in RAP-deficient mice with reduced megalin expression. Pflügers Arch 446: 475–484, 2003[CrossRef][Medline]
  17. Biemesderfer D, Nagy T, DeGray B, Aronson PS: Specific association of megalin and the Na+/H+ exchanger isoform NHE3 in the proximal tubule. J Biol Chem 274: 17518–17524, 1999[Abstract/Free Full Text]
  18. Leheste JR, Melsen F, Wellner M, Jansen P, Schlichting U, Renner-Muller I, Andreassen TT, Wolf E, Bachmann S, Nykjaer A, Willnow TE: Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 17: 247–249, 2003[Abstract/Free Full Text]
  19. Biber J, Stieger B, Haase W, Murer H: A high yield preparation for rat kidney brush border membranes: Different behaviour of lysosomal markers. Biochim Biophys Acta 647: 169–176, 1981[Medline]
  20. de Toledo FG, Thompson MA, Bolliger C, Tyce GM, Dousa TP: Gamma-L-glutamyl-L-DOPA inhibits Na(+)-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate. Kidney Int 55: 1832–1842, 1999[CrossRef][Medline]
  21. Kelly MH, Hamilton JR: A micro-technique for the assay of intestinal alkaline phosphatase: Results in normal children and in children with celiac disease. Clin Biochem 3: 33–43, 1970[Medline]
  22. Schmitt R, Ellison DH, Farman N, Rossier BC, Reilly RF, Reeves WB, Oberbaumer I, Tapp R, Bachmann S: Developmental expression of sodium entry pathways in rat nephron. Am J Physiol 276: F367–F381, 1999
  23. Bachmann S, Bosse HM, Mundel P: Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol 268: F885–F898, 1995
  24. Traebert M, Roth J, Biber J, Murer H, Kaissling B: Internalization of proximal tubular type II Na-P(i) cotransporter by PTH: Immunogold electron microscopy. Am J Physiol 278: F148–F154, 2000
  25. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE: An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96: 507–515, 1999[CrossRef][Medline]
  26. Leheste JR, Rolinski B, Vorum H, Hilpert J, Nykjaer A, Jacobsen C, Aucouturier P, Moskaug JO, Otto A, Christensen EI, Willnow TE: Megalin knockout mice as an animal model of low molecular weight proteinuria. Am J Pathol 155: 1361–1370, 1999[Abstract/Free Full Text]
  27. Hernando N, Karim-Jimenez Z, Biber J, Murer H: Molecular determinants for apical expression and regulatory membrane retrieval of the type IIa Na/Pi cotransporter. Kidney Int 60: 431–435, 2001[CrossRef][Medline]
Received for publication November 4, 2003. Accepted for publication January 21, 2004.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Vilasi, P. R. Cutillas, A. D. Maher, S. F. M. Zirah, G. Capasso, A. W. G. Norden, E. Holmes, J. K. Nicholson, and R. J. Unwin
Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F456 - F467.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Donowitz and X. Li
Regulatory Binding Partners and Complexes of NHE3
Physiol Rev, July 1, 2007; 87(3): 825 - 872.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Theilig, W. Kriz, T. Jerichow, P. Schrade, B. Hahnel, T. Willnow, M. Le Hir, and S. Bachmann
Abrogation of Protein Uptake through Megalin-Deficient Proximal Tubules Does Not Safeguard against Tubulointerstitial Injury
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1824 - 1834.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Welker, B. Geist, J.-H. Fruhauf, M. Salanova, D. A. Groneberg, E. Krause, and S. Bachmann
Role of lipid rafts in membrane delivery of renal epithelial Na+-K+-ATPase, thick ascending limb
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1328 - R1337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Capuano, D. Bacic, M. Roos, S. M. Gisler, G. Stange, J. Biber, B. Kaissling, E. J. Weinman, S. Shenolikar, C. A. Wagner, et al.
Defective coupling of apical PTH receptors to phospholipase C prevents internalization of the Na+-phosphate cotransporter NaPi-IIa in Nherf1-deficient mice
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C927 - C934.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Raila, T. E. Willnow, and F. J. Schweigert
Megalin-Mediated Reuptake of Retinol in the Kidneys of Mice Is Essential for Vitamin A Homeostasis
J. Nutr., November 1, 2005; 135(11): 2512 - 2516.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Yamagata, K. Ozono, Y. Hashimoto, Y. Miyauchi, H. Kondou, and T. Michigami
Intraperitoneal Administration of Recombinant Receptor-Associated Protein Causes Phosphaturia via an Alteration in Subcellular Distribution of the Renal Sodium Phosphate Co-Transporter
J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2338 - 2345.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
N. Deliot, N. Hernando, Z. Horst-Liu, S. M. Gisler, P. Capuano, C. A. Wagner, D. Bacic, S. O'Brien, J. Biber, and H. Murer
Parathyroid hormone treatment induces dissociation of type IIa Na+-Pi cotransporter-Na+/H+ exchanger regulatory factor-1 complexes
Am J Physiol Cell Physiol, July 1, 2005; 289(1): C159 - C167.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Bacic, P. Capuano, M. Baum, J. Zhang, G. Stange, J. Biber, B. Kaissling, O. W. Moe, C. A. Wagner, and H. Murer
Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F740 - F747.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachmann, S.
Right arrow Articles by Willnow, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachmann, S.
Right arrow Articles by Willnow, T. E.


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP